Jubilant Life Sciences to expand capacity and R&D
Jubilant Life Sciences is expanding its production capacity at Roorkee in Uttaranchal. The company has earmarked Rs 5500 million for capital expenditure (capex) in the […]
Pharmaceuticals
Sun Pharma launches Kapspargo Sprinkle in US markets
Sun Pharma has launched Kapspargo Sprinkle (metoprolol succinate) extended-release capsules in the US markets. The drug is used for the treatment of hypertension (to lower […]
Aurobindo Pharma receives USFDA approval for Bivalirudin
Aurobindo Pharma has received final USFDA approval to manufacture and market Bivalirudin injection, 250 mg/vial. The drug Bivalirudin is a generic equivalent to the reference […]
Glenmark Pharma ties up with Seqirus
Glenmark Pharmaceuticals ties up with Seqirus (Seqirus), part of Australia-based specialty biotechnology company CSL by an exclusive licensing agreement to commercialize Ryaltris in Australia and […]
Unichem Laboratories receives USFDA approval for Montelukast
Unichem Laboratories has received final USFDA approval for its Montelukast chewable tablets used for prevention and treatment of asthma. The product is a generic version […]
Cadila receives USFDA approval to market Tadalafil in US
Zydus Cadila has received final USFDA approval to market Tadalafil tablets in American markets. The drug Tadalafil is used to erectile dysfunction and enlarged prostrate. […]
Lupin receives USFDA approval for Drospirenone, Ethinyl Estradiol, Levomefolate
Lupin has received USFDA approval to market Drospirenone, Ethinyl Estradiol, Levomefolate Calcium tablets in the American market. The drug is a generic version of Bayer […]
NPPA fixes drugs of 22 formulations for bacterial infections, cardiac conditions etc.,
National Pharma Pricing Authority (NPPA) has fixed the retail and ceiling prices of 22 formulations used for treatment of various ailments including HIV, bacterial infections […]
Natco Pharma launches Posanat – antifungal injection
Natco Pharma has launched generic version of Posaconazole Injection, 300 mg/16.7ml, under its brand POSANAT. It may be noted, the drug is available for the […]
Challenges faced by bulk drug manufacturers in India
India produces over 1/5th of bulk drug production in the world. However, the bulk drugs manufacturers are facing regulatory hurdles in many area. Currently, irrespective […]